Navigation Links
Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
Date:4/19/2013

BETHESDA, Md., April 19, 2013 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation issued the following statement in response to an announcement by Vertex Pharmaceuticals Inc. regarding promising results from a Phase 2 clinical trial of its cystic fibrosis drug Kalydeco™ in combination with another potential CF therapy, VX-661. The results showed a significant improvement in lung function in people with two copies of the most common CF mutation, Delta F508, who took the combination treatment, compared with those who received a placebo. About 50 percent of people with CF in the United States have two copies of the Delta F508 mutation.

Both Kalydeco and VX-661 are designed to treat the underlying cause of CF, a faulty gene and its protein product, known as CFTR.

"This announcement is more terrific news for the CF community," said Robert J. Beall , Ph.D., president and CEO of the Cystic Fibrosis Foundation. "While these results are still very early, they show that another potential therapy from our ongoing collaboration with Vertex can be combined with Kalydeco to achieve promising improvements in health. The data further validate our strategy of using small molecule compounds to address the basic genetic defect in cystic fibrosis."

The CF Foundation played a key role in the development of Kalydeco and VX-661, as well as other experimental compounds such as VX-809, providing significant scientific, clinical and financial support. Vertex is studying Kalydeco with VX-809 in Phase 3 trials that will enroll about 1,000 people at approximately 200 clinical trial sites in North America, Europe and Australia. "The CF Foundation is deeply grateful to the people with CF, families and medical professionals who have played a role in these studies, and to the Vertex scientists wh
'/>"/>

SOURCE Cystic Fibrosis Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medical Alarm Concepts Files Information Statement and Provides Update on Corporate Activity
2. Joint Statement On The Presidents Budget From The American Society Of Clinical Oncology, Community Oncology Alliance, ION Solutions and The US Oncology Network
3. Receptos Files Registration Statement for Proposed Initial Public Offering
4. Star Scientific, Inc. Issues Statement in Response to Two Plaintiffs Purported Class Action Law Suits and Multiple Press Releases Issued by Plaintiffs Law Firms Trolling for New Clients
5. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
6. AUGS Issues Statement Opposing The Restriction Of Surgical Options For Pelvic Floor Disorders
7. Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
8. CHPA Statement on Statewide South Carolina Consumer Poll
9. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
10. Chimerix Files Registration Statement for Proposed Initial Public Offering
11. CHPA Statement on PSE Economic Study By AEI Fellow Alex Brill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 Actinobac Biomed, NovoPedics, Inc. ... with investments from Foundation Venture Capital Group (FVCG), have ... 2015 as part of the Start-Up Stadium and Company ... James M. Golubieski . The ... will be held in Philadelphia ...
(Date:5/29/2015)... 29, 2015 Eli Lilly and Company (NYSE: ... Annual Global Healthcare Conference on Tuesday, June 9, 2015. ... Elanco Animal Health, will participate in a fireside chat ... A live audio webcast will be available on the ... http://investor.lilly.com/events.cfm . A replay of the fireside chat ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina ... Guardian Research Network and Molecular Health have announced a ... molecular diagnostic decision support to the majority of cancer ... Research Network will collaborate with Molecular Health to harness ... to identify cohorts from hundreds of thousands of patients ...
Breaking Medicine Technology:Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Lilly to Participate in Goldman Sachs Global Healthcare Conference 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... 19, 2011 Business Monitor International (BMI) has announced ... The healthcare and pharmaceutical analysis ... for drugs and healthcare expenditure, imports and exports, and ... patented drugs and generics market segments. The forecasts are ...
... BEND, Wis., May 19, 2011 Leading-edge Clinical ... Research, LLC proudly receives the 2011 IQ (Innovation ... School of Management and BizTimes Media, a magazine ... and strategic insights. The revolutionary Spaulding IQ(SM) electrocardiogram ...
Cached Medicine Technology:Business Monitor International Launches Report on China's Pharmaceutical and Healthcare Industry 2Spaulding Clinical Honored at BizTech Conference 2
(Date:5/30/2015)... “ Milli the Snail ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... engages and educates children. , Interactive mobile games for children ... content and games they are playing are doing much for ...
(Date:5/29/2015)... Montclair, NJ (PRWEB) May 30, 2015 ... and ever changing local and federal regulations, we ... needs of their patients who are suffering from ... regulations,” says Srinivas Nalamachu, MD, professor of rehabilitation ... Research Institute in Overland Park, Kansas. , A ...
(Date:5/29/2015)... 29, 2015 M3 USA MDLinx.com, source ... 14 medical specialties, now offers The Smartest Rheumatologist ... of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, to ... director of MDLinx, and Caroline Tredway, editorial head of ... it will have on the physicians who participate. Says ...
(Date:5/29/2015)... May 29, 2015 The science of ... last decade. New and more efficient methods of FUE hair ... balding patients. One of the most cutting edge hair transplant ... Restoration is the technique of extracting hair from the beard ... are performed to correct male pattern baldness. Beard ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and ... all else: God does no wrong. , It’s fitting, then, ... passing is titled “God Does No Wrong.” It focuses on ... personal tragedy. , “My story has a positive message ... into something productive, something healing,” Howse said. , “God Does ...
Breaking Medicine News(10 mins):Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Turning grief from a child’s passing into virtue 2
... reporting new evidence on how studded tires wintertime fixtures ... to pavement may also damage the health of motorists ... protrusions from the rubber tread that improve traction on icy ... Research in Toxicology , a monthly journal. Anders Ljungman ...
... (MRSA) is carried in the nose (nares), it is ... site infection. Some studies have found that the heavier the ... of transmission to others and the greater risk of infection ... differences in quantity of MRSA at different body sites. A ...
... Using a thermostatic mixer valve to control the maximum ... temperature of hot bath water and should reduce the ... of Nottingham. The study, carried out in partnership ... thermostatic mixing valve (TMV) fitted to the hot and ...
... quality of life. Painful, arthritic knees, shoulders and hips ... eliminating pain and giving a person a new lease ... plastic, doctors were able to take a patient,s cells ... one with a fully functional biological joint? A team ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Jan. 4 ... receive an implantable cardioverter-defibrillator (ICD) may not need it, a ... put at higher risk of death and serious complications than ... researchers say in the Jan. 5 issue of the ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, ... cut the number of chickenpox-related hospitalizations in the United States ... a new study. And a second study has ... by the U.S. Centers for Disease Control and Prevention in ...
Cached Medicine News:Health News:Where MRSA colonizes on the human body 2Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 2Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 3Health News:Biological joints could replace artificial joints soon 2Health News:Many May Get Unneeded Implantable Defibrillators 2Health News:Many May Get Unneeded Implantable Defibrillators 3Health News:Chickenpox Vaccine Cuts Hospitalization Rates: Study 2Health News:Chickenpox Vaccine Cuts Hospitalization Rates: Study 3Health News:Chickenpox Vaccine Cuts Hospitalization Rates: Study 4
PremierEdge Stab Knives - 15....
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... versatile and uncomplicated use of the Leica ... obtained make it the instrument of choice ... cryostat applications. The open top stainless steel ... accessible and offers ample space for convenient ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
Medicine Products: